Medican A/S Revenue and Competitors

Medican A/S is a licensed pharmaceutical cannabis company headquartered in Helsinge, Denmark. Medican was founded in October 2017 and received one of the first licenses issued in the history of Denmark to produce medicinal cannabis in December 2017. Founded by experienced Danes and Americans, the Medican team has vast experience in the cannabis industry and is collectively responsible for building established cannabis businesses in Denmark, The United States of America, and Uruguay. Medican's goal is to consistently provide patients throughout the world with medicinal grade cannabis held to the highest standard of quality. Medican focuses on improving the quality of our patients lives by cultivating consistent, natural, high-quality medical cannabis with compassion, sustainability, and integrity. We strive to cultivate human connection within our company's culture and also through our products. We nurture our plants' roots, just as we nurture our core values, and recognize the relief and benefits cannabis can deliver to those in need. Driving our belief to improve quality of life for everyone through medicinal cannabis, we have expanded globally, owning 50.5% of Nube Serena BV, in Uruguay. To further our impact, we are currently aiming to increase our presence in the EU to achieve our goal to provide high-quality medicine throughout the globe. We are proud to announce that this process is already underway, beginning with a partnership with Medicinalhanf GmbH located in Germany. Medican patiently awaits an export license to send products throughout the EU to all compliant EU countries to ensure all eligible European patients have access to the incredible benefits that cannabis has to offer.